WI – GUN CRIME – Sole Survivor Of Kenosha Protests Shootings Speaks Out For First Time
Gaige Grosskreutz is the only one of three men shot during a night of protests in Kenosha, Wisconsin who survived. He tells CNN’s Sara Sidner that he’s still reliving it every day. Only one of the three men shot during a night of protests in Kenosha last month survived, and he’s still reliving it every day. “That’s all I think about,” Gaige Grosskreutz, 22, told CNN in an exclusive interview Tuesday. “I play it back in my head, I think about it all the time.” The gunshots, the screams and the chaos that followed still play out in his head as if it were August 25 again. “I think about everything all the time,” Grosskreutz said. That night, protesters in the Wisconsin city were demanding justice after an officer repeatedly shot Jacob Blake in his back while his children watched from his car. Kyle Rittenhouse, 17, is accused in the shooting during the protest that followed. He had an affinity for police his social media makes clear. He took part in a program for youth interested in becoming police officers.
Now he faces two felony charges of homicide in the deaths of Joseph Rosenbaum and Anthony M. Huber, and a felony attempted homicide charge in Grosskreutz’s incident. Rittenhouse is also facing charges of possessing a dangerous weapon while under the age of 18, which is a misdemeanor. Under Wisconsin law he is not legally allowed to possess a gun at his age. His attorney says he acted in self-defense. As Blake, a 29-year-old Black man, fought for his life at the hospital after being shot by an officer on August 23, protesters took to the streets. Police and civilians faced off the first night and the second. But on the third night, August 25, demonstrators and visibly armed civilians also faced off. Before the shooting, Rittenhouse — clutching a long rifle — told a journalist who was trailing him that he was a trained medic, according to a criminal complaint. The teenager worked part time at a YMCA before being furloughed due to Covid-19. [full article]